Gender-Affirming Hormone Therapy Reduces Depression Risk, Study Finds

Recent studies highlight the mental health benefits of gender-affirming care, specifically hormone therapy, for transgender individuals. A new study published in JAMA Network Open revealed that transgender adults who received hormone treatment experienced a 15% lower risk of moderate-to-severe depression over four years compared to those who did not receive such care. Researchers emphasized that access to hormone therapy is critical, yet many transgender youth face barriers due to restrictive laws; nearly 40% now live in states that have enacted bans on gender-affirming care. The benefits of hormone therapy have been acknowledged by health professionals, reinforcing its necessity as a medically essential treatment. However, there are growing concerns about the political climate, with policies aimed at restricting access to such care potentially exacerbating mental health disparities among transgender populations. Overall, these findings underscore the urgent need for continued support and access to gender-affirming medical services.